Alpenglow Biosciences will attend the USCAP Annual Meeting to meet with pathologists, translational researchers, and clinical teams exploring alternatives to slide-based workflows. The team will be available to discuss non-destructive 3D tissue imaging, volumetric pathology, and whole-biopsy analysis that preserve tissue for downstream applications.

Meetings with Alpenglow can cover applications such as margin assessment, immune cell mapping, tumor microenvironment analysis, and validation of spatial biomarkers using intact tissue volumes. Discussions will focus on how 3D pathology provides greater tissue sampling, spatial context across depth, and data that support research and clinical translation.